| 摘要 |
The present invention features solid compositions comprising Compound I A , I B , I C or I D , or a pharmaceutically acceptable salt thereof, in an amorphous form. Such compositions are useful for treating HCV infection. In one embodiment, Compound I A , I B , I C or I D , or a pharmaceutically acceptable salt thereof, is formulated in an amorphous solid dispersion which comprises a pharmaceutically acceptable hydrophilic polymer and preferably a pharmaceutically acceptable surfactant. |
| 申请人 |
ABBVIE BAHAMAS LTD. |
发明人 |
LIEPOLD, BERND;JUNG, TINA;HOLIG, PETER;SCHROEDER, RUDOLF;SEVER, NANCY E.;LAFOUNTAINE, JUSTIN;SINCLAIR, BRENT D.;GAO, YI;WU, JIANWEI;ERICKSON, BRYAN K.;KULLMANN, SIMON;WESTEDT, ULRICH;PAULI, MIRKO;HEITERMANN, TANJA;KOENIG, RENATO;THIEL, MADLEN;WOEHRLE, GERD |
